BackIdera Pharmaceuticals Overview

Idera Pharmaceuticals Research & Development

Research & Development expenses for IDRA.

Quarterly R&D Expenses

$4.99M
↑ 179.88% YoY

As of Mar 31, 2023

Annual R&D Expenses (TTM)

$15.40M
↑ 36.4% YoY

Trailing 12 months ending Mar 31, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin